GlobeNewswire

New Predictive Analytics, Assurance Capabilities Advance Cisco's Strategy to Reinvent the Network for Digital Business

Dela
  • Mathematical modeling and contextual insights represent the next major advancement in intent-based networking revolution
  • Waves of software innovation fuel evolution of networking portfolio toward subscription-led model
  • Cisco delivers an industry leading end-to-end intent-based networking portfolio, which spans the data center, campus, branch and edge

BARCELONA, Spain, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Cisco today announced powerful assurance innovations across its intent-based networking portfolio that will help IT teams shift from reactive to proactive. It will address the 43 percent of time IT spends troubleshooting, while making IT operations more proactive, agile and automated. The software innovations represent significant advancements in mathematical modeling and contextual insights, accelerating Cisco's strategy to reinvent the network for the digital era.

Over the past few years, the explosion of devices, adoption of cloud, and exponential growth of security threats have challenged current approaches for building and managing networks. Cisco's vision is to create a network that anticipates operational issues, stops security threats in their tracks, and continues to learn, adapt and protect. To realize this, Cisco is driving the intent-based networking revolution by transforming the entire network, from the data center and campus, to the branch and edge.

Today, Cisco is introducing its second wave of intent-based networking innovation, with powerful assurance products spanning the networking portfolio. 

  • In the data center, the Cisco Network Assurance Engine uses continuous verification of the entire network to help keep business running as intended, even as the network changes dynamically.
  • In campus and branch networks, Cisco DNA Center Assurance is delivering a new level of insight and visibility to dramatically reduce the time and money IT spends troubleshooting across wired and wireless environments.
  • And, for customers with distributed IT operations, the new Cisco Meraki Wireless Health reduces mean time to remediate wireless issues with rich analytics and insights.

"The network has never been more critical to business success," said David Goeckeler, executive vice president, Networking and Security Business at Cisco. "We're reinventing the network ground up to deliver a secure and intelligent platform for digital business. Today, we are taking another major step toward that ambitious goal with intent-based networking innovations designed to deliver contextual insights and assurance that will help transform IT from reactive to proactive."

Cisco's intent-based networking portfolio represents a fundamental shift away from the manual and time-intensive methods by which networks are traditionally managed. These intent-based networks capture and translate business intent into network policies, and activate them across the infrastructure. With the introduction of assurance capabilities, they can now continuously verify the network is operating as intended.

Customers globally are embracing intent-based networking. Nearly 200 customers are in early field trails with the new assurance technologies, including Robert Bosch GmbH, REWE Group, Houston Methodist Hospital and Scotiabank. More than 1,100 customers are deploying the recently announced Catalyst 9000 Series switches, with 150 running DNA Center pilots. In the data center, Cisco has more than 14,500 Nexus 9000 customers, with a 45 percent ACI attach rate.

Innovation Spanning Data Center and Enterprise Networking 
Today, Cisco is introducing three powerful new assurance products that further demonstrate how intent-based networking systems move at the speed of digital business.

In the data center network, Cisco is enabling always-on assurance through the Cisco Network Assurance Engine. By combining mathematically accurate models of the network with more than 30 years of codified domain knowledge, Cisco provides IT teams the ability to instantly pinpoint why and when the network is not acting as intended, then offer suggestions on how to address the issue. This comprehensive view into their network helps enable IT teams to:

  • Predict the Impact of Changes: Make changes to the network faster and with more confidence, catching human configuration errors before they cause problems.
  • Continuously Verify Network Behavior: Proactively eliminate network outages and vulnerabilities by continuously analyzing the state of the entire network.
  • Assure Security Policy and Compliance: Reduce risk by assuring that security policies are being applied consistently across the network, and ensure policies are compliant with business requirements-every minute of every day.

With ACI and Tetration, Cisco provides the ability to translate application intent and activate those policies across the network. Now, with the Network Assurance Engine, Cisco is delivering the final element of intent-based networking - the assurance of intent.

In the campus and branch, Cisco is enabling 'everything as a sensor' and aggregating intelligence from the network, application, client and things to help provide IT with full context. These capabilities will dramatically reduce the 43 percent of time that IT spends troubleshooting and improve the experience for employees and customers.

Cisco DNA Center Assurance provides a 360-degree contextual view that connects all the relationships of who, what, where, when, how. Spanning wired and wireless environments, it delivers a complete picture of what is happening between users and applications with real-time, historical and predictive capabilities. DNA Center Assurance helps IT teams address three major issues:

  • Problem Isolation: Get to the root cause in minutes-not days or weeks-by isolating where exactly the issue happened.
  • Problem Replication: Go back in time to when an issue occurred. IT can view a complete 360 snapshot of the status of the network, user, device and application at the exact moment the issue arose.
  • Problem Resolution: Proactively fix the issue through guided remediation.

With Cisco Meraki Wireless Health, IT also gains visibility and rich analytics to troubleshoot wireless issues faster and deliver a better user experience. Cisco Meraki uses a cloud-managed IT model to automate operations, simplifying the complexity of IT. Now, Meraki Wireless Health allows IT teams to quickly identify wireless anomalies, find poorly performing access point and clients, and provide actionable insights to improve the wireless experience.

Powered by network analytics and rich contextual data, Cisco Services offers new services to help customers streamline the deployment of the new assurance solutions. From advisory and implementation, through optimization and managed services, Cisco and its partners are helping customers accelerate their journey to truly intent-based networks.

Customer Quotes
Robert Bosch GmbHJan Holzmann, Team Lead for Data Center Network Operations
"We are constantly bringing on new applications and expanding our data center capacity as we expand our business. The Cisco Network Assurance Engine helps enable a new level of quality for our application migrations. With a detailed understanding of the policy model and proactive verification of all changes, Cisco Network Assurance Engine can help us greatly reduce the risk of production outages and accelerate our timelines."

Houston Methodist Hospital, Manuel Ortiz III, Senior Wireless Engineer
"DNA Center helps me find problems proactively, before users contact me. With a mostly wireless network, I'm able to find devices throughout the network and quickly solve any problems with the help of analytics."

Axians Nordic, Erik Sohlman, Senior Manager and CTO
"As a Cloud Service Provider, our business depends on network availability and delivering on customer SLAs. We are always looking for modern technologies to manage our multiple data centers and remain an industry leader.  Cisco Network Assurance Engine's approach of 'always on assurance' for our network and services will make our operating model more proactive and help enable us to remain as the best-in-class service provider to our customers."

REWE Group, Hans Vasters, Senior Network Architect
"Cisco DNA Center allows the networking team to focus on our core projects and give more responsibility to the first line support team. It lets our team be proactive when it comes to resolving issues, before it becomes a problem to our users."

Scotiabank, Nicholas Yurkovich Chief Network Engineer
"The more intuitive that I can make troubleshooting, the sooner I can take the network out of the equation. With Cisco DNA Center Assurance, the Scotiabank first line support teams can now take a proactive approach to resolving wireless issues and the engineering networking teams can work on growth and forward-looking opportunities."

West Corporation, Tania Mazza, Director, Network Engineering
"At West, we run critical communications infrastructure for our customers, and as such, scale and speed are vital for our operations. Using the change verification process, we see Cisco Network Assurance Engine as a way to achieve higher levels of automation with increased certainty, allowing us to confidently move at a faster pace."

Availability

  • The Cisco Network Assurance Engine is available now, initially for Cisco ACI customers, with a free, 30-day, no-commitment trial. Customers can purchase it via software subscription.
  • Cisco DNA Center Assurance is available now. Customers can purchase it via the Cisco ONE subscription offer for networking.
  • Cisco Meraki Wireless Health is expected to be available in early 2018. It will be included with the standard subscription for Meraki Wireless Access Points.

Additional Resources

About Cisco
Cisco (NASDAQ:CSCO) is the worldwide technology leader that has been making the Internet work since 1984. Our people, products, and partners help society securely connect and seize tomorrow's digital opportunity today. Discover more at newsroom.cisco.com and follow us on Twitter at @Cisco.

Cisco and the Cisco logo are trademarks or registered trademarks of Cisco and/or its affiliates in the United States and certain other countries. A listing of Cisco's trademarks can be found at  www.cisco.com/go/trademarks .  All other trademarks mentioned are the property of their respective owners. The use of the word partner does not imply a partnership relationship between Cisco and any other company. Many of the products and features described herein remain in varying stages of development and will be offered on a when-and-if-available basis. This roadmap is subject to change at the sole discretion of Cisco, and Cisco will have no liability for delay in the delivery or failure to deliver any of the products or features set forth in this document. This document is Cisco Public Information.

RSS Feed for Cisco: http://newsroom.cisco.com/rss-feeds

Gareth Pettigrew
Cisco
+1 (604) 647-2326 
gpettigr@cisco.com

Lee Davis                                                                                              
Cisco                                                                                                           
650-868-3036                                                                                                                    
leedavis@cisco.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Cisco via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Stillfront: Simutronics återtar förläggartjänster10.12.2018 14:11Pressmeddelande

PRESSMEDDELANDE 2018-12-10 Simutronics återtar förläggartjänster för SIEGE: Titan Wars globalt med undantag för Kina Simutronics, en studio inom Stillfront Group, har avslutat ett medförläggaravtal avseende mobilspelet SIEGE: Titan Wars med den New York-baserade förläggarpartnern Tilting Point. Enligt ett nytt avtal kommer Tilting Point fortsatt att tillhandahålla förläggartjänster och marknadsföring av spelet i Kina men på global nivå kommer Simutronics att ansvara för förläggartjänster och marknadsföring av spelet från gruppen. Simutronics är en ledande utvecklare av rollspel och mobila spel som till exempel DragonRealms, GemStone IV och Lara Croft Relic Run, den sistnämnda med mer än 23 miljoner nedladdningar. Tilting Point är den nya generationens spelbolagspartner som förser ledande utvecklingsstudios med expertis, tjänster och operationell support för att optimera högkvalitativa livespel framgångsrikt. "Jag är mycket nöjd över det fortsatta partnerskapet med Tilting Point för den

Stillfront: Simutronics reclaims publishing services10.12.2018 14:11Pressmeddelande

PRESS RELEASE December 10, 2018 Simutronics reclaims the publishing services for SIEGE: Titan Wars globally except China Simutronics Corp, a studio within Stillfront Group AB, has ended a co-publishing agreement regarding the mobile game SIEGE: Titan Wars with New York based publishing partner Tilting Point. According to a new agreement, Tilting Point will continue to provide publishing services and market the game in China but Simutronics will run the publishing services and marketing globally from the Group going forward. Simutronics is a leading developer of online roleplaying and mobile games such as DragonRealms, GemStone IV and Lara Croft Relic Run, the latter with more than 23 million downloads. Tilting Point is a new-generation games partner that provides top development studios with expert resources, services, and operational support to optimize high quality live games for success. "I am very pleased to continue the partnership with Tilting Point for the Chinese market as this

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

Corline Biomedical AB: Patientrekrytering startar i Renaparin-studie30.11.2018 16:37Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att patientrekrytering i den kliniska fas 1-studien RENAPAIR-01 startar. I studien utvärderas bolagets läkemedelskandidat Renaparin® som är under utveckling för att förbättra utfallet av njurtransplantation. Patienter kommer inledningsvis att rekryteras på Akademiska sjukhuset i Uppsala. När de fyra första patienterna utvärderats inleds också rekrytering på Karolinska Universitetssjukhuset i Huddinge. Beskedet att patientrekrytering startar innebär att förberedelsearbetet inför studiestart är avslutat och att till exempel avtal, initieringsmöte, logistik, provhantering och monitorering är hanterat, samt att godkänt prövningsläkemedel nu finns tillgängligt för rekvirering av kirurgerna på transplantationskliniken i Uppsala för dosering till donatornjurar. När första patient doserats kommer detta meddelas separat. Corline har utvecklat och äger rättigheterna till Renaparin® som administreras direkt till den donerade njuren i

Stillfront: Bytro Labs lanserar en ny version av Supremacy 191427.11.2018 08:00Pressmeddelande

PRESSMEDDELANDE 2018-11-27 Bytro Labs, en studio inom Stillfront Group, lanserar en ny version av Supremacy 1914 Spelutvecklaren Bytro Labs, mest kända för sitt framgångsrika strategispel Call of War, har släppt en ny version av sin klassiska speltitel Supremacy 1914. Dagens lansering är den första av tre milstolpar för den nya versionen av Supremacy 1914 - The Great War som släpps 2019. Den första uppdateringen innehåller en komplett omarbetning av området för spelets community, ett nytt utseende för kartan samt ny 3D-teknologi. I nästa steg kommer Bytro Labs att gå vidare till "true cross platform" där spelet tillgängliggörs för fler plattformar, en strategi som tidigare har varit framgångsrik för titeln Call of War. Supremacy 1914 - The Great War släpps för Android senare i år och i början av 2019 släpps spelet för iOS och Steam. Det tredje och sista steget i lanseringen kommer i mitten av 2019 innehållande en större uppdatering avseende både innehåll och funktion, som färdigställer

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum